Literature DB >> 4550769

Antigenic properties of murine sarcoma virus-transformed BALB-3T3 nonproducer cells.

J R Stephenson, S A Aaronson.   

Abstract

The isolation of clonal lines of murine sarcoma virus-transformed, non-producer BALB/3T3 cells has provided a model system for determining whether RNA tumor virus-transformed cells possess virus-specific transplantation antigens. MSV nonproducer cells (K-234) were clonally derived from an inbred mouse cell line, BALB/3T3. A parallel virus-producing cell line was obtained by infection of the MSV nonproducer cells with Rauscher leukemia virus. K-234 was much more tumorigenic than K-234(R). Preimmunization of syngeneic mice with either K-234(R) or with UV-inactivated Rauscher leukemia virus induced transplantation resistance to subsequent challenge with K-234(R), but not with K-234. In contrast, mice preimmunized with nonproducer cells were not made resistant to subsequent challenge with the homologous cells. Antisera prepared from mice immunized with K-234(R) were specifically cytotoxic and positive by fluorescent antibody staining for K-234(R) target cells, but not to either BALB/3T3 or K-234. The results show that MSV nonproducer cells lack detectable transplantation antigens and suggest that the transplantation resistance to the producing cells is attributable to maturing virus at the cell surface.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4550769      PMCID: PMC2139135          DOI: 10.1084/jem.135.3.503

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  21 in total

1.  Antigenic properties of a nonreleaser neoplasm induced in the mouse by murine sarcoma virus.

Authors:  L W Law; R C Ting
Journal:  J Natl Cancer Inst       Date:  1970-03       Impact factor: 13.506

2.  Development of 3T3-like lines from Balb-c mouse embryo cultures: transformation susceptibility to SV40.

Authors:  S A Aaronson; G J Todaro
Journal:  J Cell Physiol       Date:  1968-10       Impact factor: 6.384

3.  Basis for the acquisition of malignant potential by mouse cells cultivated in vitro.

Authors:  S A Aaronson; G J Todaro
Journal:  Science       Date:  1968-11-29       Impact factor: 47.728

4.  Antigenicity of a virus-induced murine sarcoma (Moloney).

Authors:  A Fefer; J L McCoy; J P Glynn
Journal:  Cancer Res       Date:  1967-05       Impact factor: 12.701

5.  Virus-induced transplantation immunity to human adenovirus type 12 tumors of the hamster and mouse.

Authors:  J J Trentin; E Bryan
Journal:  Proc Soc Exp Biol Med       Date:  1966-04

6.  Induction and regression of primary moloney sarcoma virus-induced tumors in mice.

Authors:  A Fefer; J L McCoy; J P Glynn
Journal:  Cancer Res       Date:  1967-09       Impact factor: 12.701

7.  Cellular antigen of Friend virus-induced leukemias.

Authors:  R A Steeves
Journal:  Cancer Res       Date:  1968-02       Impact factor: 12.701

8.  Genetic origin of tumor antigens.

Authors:  E A Boyse; L J Old; E Stockert; N Shigeno
Journal:  Cancer Res       Date:  1968-07       Impact factor: 12.701

9.  Rescue of the defective genome of Moloney sarcoma virus from a noninfectious hamster tumor and the production of pseudotype sarcoma viruses with various murine leukemia viruses.

Authors:  R J Huebner; J W Hartley; W P Rowe; W T Lane; W I Capps
Journal:  Proc Natl Acad Sci U S A       Date:  1966-10       Impact factor: 11.205

10.  Persistent infection of a rat kidney cell line with Rauscher murine leukemia virus.

Authors:  E N Rosenblum; R F Zeigel
Journal:  J Bacteriol       Date:  1966-10       Impact factor: 3.490

View more
  22 in total

1.  Polypeptides of cells transformed by RNA or DNA tumor viruses.

Authors:  M Strand; J T August
Journal:  Proc Natl Acad Sci U S A       Date:  1977-07       Impact factor: 11.205

2.  Abelson antigen: a viral tumor antigen that is also a differentiation antigen of BALB/c mice.

Authors:  R Risser; E Stockert; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

3.  Absence of a specific ganglioside galactosyltransferase in mouse cells transformed by murine sarcoma virus.

Authors:  P H Fishman; R O Brady; R M Bradley; S A Aaronson; G J Todaro
Journal:  Proc Natl Acad Sci U S A       Date:  1974-02       Impact factor: 11.205

4.  Selection of revertants of Kirsten sarcoma virus transformed nonproducer BALB-3T3 cells.

Authors:  B Ozanne; A Vogel
Journal:  J Virol       Date:  1974-08       Impact factor: 5.103

5.  Demonstration of a cell-surface antigen associated with murine sarcoma virus by immunoelectron microscopy.

Authors:  T Aoki; J R Stephenson; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1973-03       Impact factor: 11.205

6.  Immunity to tumours of the murine leukaemia-sarcoma virus complex.

Authors:  J J Owen; R C Seeger
Journal:  Br J Cancer Suppl       Date:  1973-08

7.  Expression and CTL recognition of cloned subgenomic fragments of Moloney murine leukemia virus in murine cells.

Authors:  D C Flyer; S J Burakoff; D V Faller
Journal:  Surv Immunol Res       Date:  1985

8.  Tumorigenicity, immunogenicity, and virus production in mouse melanoma cells treated with 5-bromodeoxyuridine.

Authors:  S Silagi; D Beju; J Wrathall; E Deharven
Journal:  Proc Natl Acad Sci U S A       Date:  1972-11       Impact factor: 11.205

9.  Species and interspecies radioimmunoassays for rat type C virus p30: interviral comparisons and assay of human tumor extracts.

Authors:  H P Chapman; M H White; R Rahman; R V Gilden
Journal:  J Virol       Date:  1975-01       Impact factor: 5.103

10.  Surface antigens of mammalian sarcoma virus-transformed nonproducer cells.

Authors:  T Aoki; J R Stephenson; S A Aaronson; K C Hsu
Journal:  Proc Natl Acad Sci U S A       Date:  1974-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.